Poststroke Depression

A Scientific Statement for Healthcare Professionals from the American Heart Association/American Stroke Association

American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Quality of Care and Outcomes Research

Research output: Contribution to journalReview article

65 Citations (Scopus)

Abstract

Poststroke depression (PSD) is common, affecting approximately one third of stroke survivors at any one time after stroke. Individuals with PSD are at a higher risk for suboptimal recovery, recurrent vascular events, poor quality of life, and mortality. Although PSD is prevalent, uncertainty remains regarding predisposing risk factors and optimal strategies for prevention and treatment. This is the first scientific statement from the American Heart Association on the topic of PSD. Members of the writing group were appointed by the American Heart Association Stroke Council's Scientific Statements Oversight Committee and the American Heart Association's Manuscript Oversight Committee. Members were assigned topics relevant to their areas of expertise and reviewed appropriate literature, references to published clinical and epidemiology studies, clinical and public health guidelines, authoritative statements, and expert opinion. This multispecialty statement provides a comprehensive review of the current evidence and gaps in current knowledge of the epidemiology, pathophysiology, outcomes, management, and prevention of PSD, and provides implications for clinical practice.

Original languageEnglish (US)
Pages (from-to)e30-e43
JournalStroke
Volume48
Issue number2
DOIs
StatePublished - Feb 1 2017

Fingerprint

Stroke
Delivery of Health Care
Epidemiology
American Heart Association
Manuscripts
Expert Testimony
Causality
Uncertainty
Blood Vessels
Survivors
Public Health
Quality of Life
Guidelines
Mortality
Therapeutics
Clinical Studies

Keywords

  • AHA Scientific Statements
  • depression
  • management
  • prevention & control
  • screening
  • stroke
  • treatment

ASJC Scopus subject areas

  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine
  • Advanced and Specialized Nursing

Cite this

American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, & Council on Quality of Care and Outcomes Research (2017). Poststroke Depression: A Scientific Statement for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke, 48(2), e30-e43. https://doi.org/10.1161/STR.0000000000000113

Poststroke Depression : A Scientific Statement for Healthcare Professionals from the American Heart Association/American Stroke Association. / American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Quality of Care and Outcomes Research.

In: Stroke, Vol. 48, No. 2, 01.02.2017, p. e30-e43.

Research output: Contribution to journalReview article

American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing & Council on Quality of Care and Outcomes Research 2017, 'Poststroke Depression: A Scientific Statement for Healthcare Professionals from the American Heart Association/American Stroke Association', Stroke, vol. 48, no. 2, pp. e30-e43. https://doi.org/10.1161/STR.0000000000000113
American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Quality of Care and Outcomes Research. Poststroke Depression: A Scientific Statement for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke. 2017 Feb 1;48(2):e30-e43. https://doi.org/10.1161/STR.0000000000000113
American Heart Association Stroke Council ; Council on Cardiovascular and Stroke Nursing ; Council on Quality of Care and Outcomes Research. / Poststroke Depression : A Scientific Statement for Healthcare Professionals from the American Heart Association/American Stroke Association. In: Stroke. 2017 ; Vol. 48, No. 2. pp. e30-e43.
@article{3a3b413d9b4043ffb8c07164d486fa42,
title = "Poststroke Depression: A Scientific Statement for Healthcare Professionals from the American Heart Association/American Stroke Association",
abstract = "Poststroke depression (PSD) is common, affecting approximately one third of stroke survivors at any one time after stroke. Individuals with PSD are at a higher risk for suboptimal recovery, recurrent vascular events, poor quality of life, and mortality. Although PSD is prevalent, uncertainty remains regarding predisposing risk factors and optimal strategies for prevention and treatment. This is the first scientific statement from the American Heart Association on the topic of PSD. Members of the writing group were appointed by the American Heart Association Stroke Council's Scientific Statements Oversight Committee and the American Heart Association's Manuscript Oversight Committee. Members were assigned topics relevant to their areas of expertise and reviewed appropriate literature, references to published clinical and epidemiology studies, clinical and public health guidelines, authoritative statements, and expert opinion. This multispecialty statement provides a comprehensive review of the current evidence and gaps in current knowledge of the epidemiology, pathophysiology, outcomes, management, and prevention of PSD, and provides implications for clinical practice.",
keywords = "AHA Scientific Statements, depression, management, prevention & control, screening, stroke, treatment",
author = "{American Heart Association Stroke Council} and {Council on Cardiovascular and Stroke Nursing} and {Council on Quality of Care and Outcomes Research} and Amytis Towfighi and Bruce Ovbiagele and {El Husseini}, Nada and Hackett, {Maree L.} and Jorge, {Ricardo E.} and Kissela, {Brett M.} and Mitchell, {Pamela H.} and Skolarus, {Lesli E.} and Whooley, {Mary A.} and Linda Williams",
year = "2017",
month = "2",
day = "1",
doi = "10.1161/STR.0000000000000113",
language = "English (US)",
volume = "48",
pages = "e30--e43",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Poststroke Depression

T2 - A Scientific Statement for Healthcare Professionals from the American Heart Association/American Stroke Association

AU - American Heart Association Stroke Council

AU - Council on Cardiovascular and Stroke Nursing

AU - Council on Quality of Care and Outcomes Research

AU - Towfighi, Amytis

AU - Ovbiagele, Bruce

AU - El Husseini, Nada

AU - Hackett, Maree L.

AU - Jorge, Ricardo E.

AU - Kissela, Brett M.

AU - Mitchell, Pamela H.

AU - Skolarus, Lesli E.

AU - Whooley, Mary A.

AU - Williams, Linda

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Poststroke depression (PSD) is common, affecting approximately one third of stroke survivors at any one time after stroke. Individuals with PSD are at a higher risk for suboptimal recovery, recurrent vascular events, poor quality of life, and mortality. Although PSD is prevalent, uncertainty remains regarding predisposing risk factors and optimal strategies for prevention and treatment. This is the first scientific statement from the American Heart Association on the topic of PSD. Members of the writing group were appointed by the American Heart Association Stroke Council's Scientific Statements Oversight Committee and the American Heart Association's Manuscript Oversight Committee. Members were assigned topics relevant to their areas of expertise and reviewed appropriate literature, references to published clinical and epidemiology studies, clinical and public health guidelines, authoritative statements, and expert opinion. This multispecialty statement provides a comprehensive review of the current evidence and gaps in current knowledge of the epidemiology, pathophysiology, outcomes, management, and prevention of PSD, and provides implications for clinical practice.

AB - Poststroke depression (PSD) is common, affecting approximately one third of stroke survivors at any one time after stroke. Individuals with PSD are at a higher risk for suboptimal recovery, recurrent vascular events, poor quality of life, and mortality. Although PSD is prevalent, uncertainty remains regarding predisposing risk factors and optimal strategies for prevention and treatment. This is the first scientific statement from the American Heart Association on the topic of PSD. Members of the writing group were appointed by the American Heart Association Stroke Council's Scientific Statements Oversight Committee and the American Heart Association's Manuscript Oversight Committee. Members were assigned topics relevant to their areas of expertise and reviewed appropriate literature, references to published clinical and epidemiology studies, clinical and public health guidelines, authoritative statements, and expert opinion. This multispecialty statement provides a comprehensive review of the current evidence and gaps in current knowledge of the epidemiology, pathophysiology, outcomes, management, and prevention of PSD, and provides implications for clinical practice.

KW - AHA Scientific Statements

KW - depression

KW - management

KW - prevention & control

KW - screening

KW - stroke

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=85004066465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85004066465&partnerID=8YFLogxK

U2 - 10.1161/STR.0000000000000113

DO - 10.1161/STR.0000000000000113

M3 - Review article

VL - 48

SP - e30-e43

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 2

ER -